Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Penumbra Inc One Penumbra Place Alameda CA 94502 USA

www.penumbrainc.com P: 510-748-3200

Description:

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Key Statistics

Overview:

Market Capitalization, $K 7,856,910
Enterprise Value, $K 7,689,420
Shares Outstanding, K 38,704
Annual Sales, $ 1,059 M
Annual Net Income, $ 90,950 K
Last Quarter Sales, $ 284,680 K
Last Quarter Net Income, $ 54,220 K
EBIT, $ 73,560 K
EBITDA, $ 100,820 K
60-Month Beta 0.51
% of Insider Shareholders 5.30%
% of Institutional Shareholders 88.88%
Float, K 36,653
% Float 94.70%
Short Volume Ratio 0.33

Growth:

1-Year Return -26.51%
3-Year Return -32.78%
5-Year Return 55.73%
5-Year Revenue Growth 137.90%
5-Year Earnings Growth 309.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.76 on 02/22/24
Latest Earnings Date 05/07/24
Earnings Per Share ttm 2.09
EPS Growth vs. Prev Qtr 13.43%
EPS Growth vs. Prev Year 375.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PEN Ratios

Ratio
Price/Earnings ttm 97.00
Price/Earnings forward 70.87
Price/Earnings to Growth 1.99
Return-on-Equity % 7.49%
Return-on-Assets % 5.60%
Profit Margin % 8.59%
Debt/Equity 0.00
Price/Sales 7.41
Price/Cash Flow 71.38
Price/Book 6.61
Book Value/Share 30.54
Interest Coverage -1.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar